Status: Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
This trial is a randomized, double-blind, placebo-controlled multicenter phase III clinical study aiming to evaluate the efficacy and safety of LBL-024 compared with placebo in combination with etoposide and cisplatin or carboplatin (EP or EC) for the first-line treatment of advanced EP-NEC patients.
Participants needed: 280
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Nanjing Leads Biolabs Co.,LtdUpdated: Jul 24, 2026Locations: 17
Eligibility criteria
Agrees to follow the investigational treatment protocol, visit schedule and labo... [+5]
Diagnosed with Mixed neuroendocrine-non endocrine neoplasm (MiNENs). [+8]